Tag: Uterine serous carcinoma (USC)

Unleashing Hope: Breakthroughs in Uterine Serous Carcinoma Treatment Revolutionize the Market

Uterine serous carcinoma (USC) is a rare but aggressive form of endometrial cancer that accounts for approximately 10% of all endometrial cancer cases. It is characterized by its high propensity for metastasis and poor prognosis. Despite its rarity, USC poses a significant challenge to healthcare providers and patients alike, necessitating the urgent need for effective […]

Back To Top